https://doi.org/10.4081/monaldi.2012.131

Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension

Vol. 78 No. 2 (2012): Cardiac series
Submitted: December 1, 2015
Accepted: December 1, 2015
Published: December 1, 2015
pulmonary arterial hypertension, thalassemia major, sildenafil.
Abstract Views: 923
PDF: 636
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Michele Correale
opsfco@tin.it
University of Foggia, Department of Cardiology, Italy.
Fiorella De Rosa
University of Foggia, Department of Cardiology, Italy.
Riccardo Ieva
University of Foggia, Department of Cardiology, Italy.
Matteo Di Biase
Professor, University of Foggia, Department of Cardiology, Italy.
Natale Daniele Brunetti
Assist Professor, University of Foggia, Department of Cardiology, Italy.
We report a case of a 37-years-old man, affected by thalassemia major, hypogonadotropic hypogonadism, chronic HCV-hepatitis, diabetes mellitus, severe osteoporosis, prior septic pulmonary embolism and pulmonary artery hypertension was performed a long-term treatment with highdose of sildenafil (120 mg/die) with reduction of pulmonary arterial systolic pressure and of the dyspnea.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Correale, Michele, Fiorella De Rosa, Riccardo Ieva, Matteo Di Biase, and Natale Daniele Brunetti. 2015. “Long-Term Treatment With High-Dose of Sildenafil in a Thalassemic Patient With Pulmonary Hypertension”. Monaldi Archives for Chest Disease 78 (2). https://doi.org/10.4081/monaldi.2012.131.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.